An Update on COVID-19 Activities for Rare Disease

April 1, 2020

As the situation with the novel coronavirus and COVID-19 continues to change, Kimberly Haugstad, CEO, Global Genes wants you to know that we still advocating for the rare disease community. Watch this brief message for updates on what Global Genes is doing during this crisis. As always, if you need something, please do not hesitate to contact us. And for more resources, please visit out COVID-19 Resource page.

Stay Connected

Facebook Twitter Instagram Youtube

An Update on COVID-19 Activities for Rare Disease

Related

Expanding Access to Genome Sequencing in Rural Populations & More — This Week in RARE Daily

Two Rare Disease Drug Developers Raise Combined $152.5 Million in PIPE Offerings

Financings of Public Rare Disease Drug Developers Soar & More — This Week in RARE Daily

Promise and Challenges of Gene-Editing and Other Genomic Medicines — 2024 NEXT Report

NCATS Seeks Applicants for Rare Disease Clinical Research Funding & More — This Week in RARE Daily

The Impact of Grants Provided For Ukraine Relief

Mental Health Resources for the Rare Disease Community

Celebrating the Most Expensive Drug for the Disease You Never Heard Of & More — This Week in RARE Daily

The Vital Role of Education in Patient Advocacy: A Gene Therapy Perspective

Stay Connected